Aluminum exposure in premature babies related to total parenteral nutrition and treatments

Aluminum exposure in premature babies related to total parenteral nutrition and treatments

This study aimed to measure aluminum contamination of parenteral nutrition(PN) solutions and aluminum contents of parenteral products given tonewborn infants for nutrition or treatment. In this study, the aluminumcontent of the first products used to prepare PN solutions for prematureneonates, of the final parenteral products prepared therefrom, and of theparenteral drugs frequently used in newborn units was measured using theinductively coupled plasma mass spectrometry. The aluminum contaminationof all parenteral nutritional products evaluated, except for one, was detectedto be over the recommended doses. Of all the first products analyzed withinthe scope of the study, trace-element preparation, preparation containingfat-soluble vitamins, 20% dextrose solution, calcium gluconate ampoule andsodium phosphate ampoule indicated high aluminum contamination. Thetotal aluminum content of the prepared final products was identified to be atleast 40% higher than the total aluminum content of the ingredients addedto the compound. Accordingly, the minimum amount of aluminum contentwas measured as 233 μg/kg/day in nutrition solutions prepared for a babyweighing 1,000 g. Contamination was detected in 9 of the 18 drugs evaluated.This study indicated that the rate of aluminum exposure of the prematurebabies receiving parental nutrition is still much higher than the safe dosesrecommended as 5 µg/kg/day by the FDA. Products with lower aluminumcontent should be preferred in the care of premature infants.

___

  • 1. Lukiw WJ. Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics. J Inorg Biochem 2010; 104: 1010-1012.
  • 2. Fanni D, Ambu R, Gerosa C, et al. Aluminum exposure and toxicity in neonates: A practical guide to halt aluminum overload in the prenatal and perinatal periods. World J Pediatr 2014; 10: 101-107.
  • 3. Bishop NJ, Morley R, Chir B, Day P, Lucas A. Aluminum neurotoxıcıty in preterm infants receiving intravenousfeeding solutions. N Engl J Med 1997; 336: 1557-1561.
  • 4. Nehra D, Carlson SJ, Fallon EM, et al. A.S.P.E.N. Clinical Guidelines: Nutrition support of neonatal patients at risk for metabolic bone disease. J Parenter Enter Nutr 2013; 37: 570-598.
  • 5. Smith BS, Kothari H, Hayes BD, et al. Effect of additive selection on calculated aluminum content of parenteral nutrient solutions. Am J Health Syst Pharm 2007; 64: 730-739.
  • 6. Bishop NJ, Robinson MJ, Lendon M, Hewitt CD, Day JP, O’hara M. Increased concentration of aluminium in the brain of a parenterally fed preterm infant. Arch Dis Child 1989; 64: 1316-1317.
  • 7. von Stockhausen HB, Schrod L, Brätter P, Rösick U. Aluminium loading in premature infants during intensive care as related to clinical aspects. J Trace Elem Electrolytes Health Dis 1990; 4: 209-213.
  • 8. Fewtrell MS, Bishop NJ, Edmonds CJ, Isaacs EB, Lucas A. Aluminum exposure from parenteral nutrition in preterm infants: Bone health at 15-year follow-up. Pediatrics 2009; 124: 1372-1379.
  • 9. Food and Drug Administration. Aluminum in larger and small volume parenterals used in total parenteral nutrition; amendment; delay of effective date. Fed Reg 2002; 67: 70691-70692.
  • 10. Poole RL, Pieroni KP, Gaskari S, Dixon T, Kerner JA. Aluminum exposure in neonatal patients using the least contaminated parenteral nutrition solution products. Nutrients 2012; 4: 1566-1574.
  • 11. Klein GL, Alfrey AC, Shike M, Sherrard DJ. Parenteral drug products containing aluminum as an ingredient or a contaminant: Response to FDA notice of intent. Am J Clin Nutr 199l; 53: 399-402.
  • 12. Huston RK, Heisel CF, Vermillion BR, Christensen JM, Minc L. Aluminum content of neonatal parenteral nutrition solutions: Options for reducing aluminum exposure. Nutr Clin Pract 2017; 32: 266-270.
  • 13. de Oliveira SR, Bohrer D, Garcia SC, do Nascimento PC, Noremberg S. Aluminum content in intravenous solutions for administration to neonates: Role of product preparation and administration methods. J Parenter Enteral Nutr 2010; 34: 322-328.
  • 14. Keith S, Jones D, Rosemond Z, Ingerman L, Chappell L. Toxicological Profile for Aluminum. 2008. Available from: https://www.atsdr.cdc.gov/toxprofiles/tp22.pdf Accessed on 11.08.2017.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Response to ''Is the BCS1L variant c.232A>G truly responsible for a GRACILE-like condition?''

Şahin Takcı, Şule Yiğit, Esra Serdaroğlu, Vineta Fellman

Changes in trajectories of physical growth in a domestic adoptees sample: A preliminary study

Pietro FERRARA, Costanza CUTRONA, Chiara GUADAGNO, Maria Elisa AMODEO, Ester Del VESCOVO, Francesca IANNİELLO, Tommasangelo PETİTTİ

An asthmatic child with allergic bronchopulmonary aspergillosis (ABPA)

Öner ÖZDEMİR

The association between monosymptomatic enuresis and allergic diseases in children

Caner Alparslan, Demet Alaygut, Suzan Yılmaz Durmuş, Seda Şirin Köse, Özden Anal, Alper Soylu

Determinants of childhood diarrhea among under-five year old children in Nigeria: A population-based study using the 2013 demographic and health survey data

Anselm S. BERDE, Sıddika Songül YALÇIN, Hilal ÖZCEBE, Sarp ÜNER, Özge KARADAĞ ÇAMAN

Perfusion index and pleth variability index in the first hour of life according to mode of delivery

Şule YİĞİT, Şahin TAKÇI, Davut BOZKAYA, Murat YURDAKÖK

Changes of primary headache related white matter lesions in pediatric patients

Erhan BAYRAM, Uluç YİŞ, Cem PAKETÇİ, Derya OKUR, İpek POLAT, Handan ÇAKMAKÇI, Semra HIZ, Banu ANLAR

A rare cause of facial nerve palsy in a young infant: Kawasaki disease

Ali ORGUN, Cüneyt KARAGÖL, Utku PAMUK, Hazım Alper GÜRSU, İlker ÇETİN

Doxylamine succinate overdose: Slurred speech and visual hallucination

Okşan Derinöz GÜLERYÜZ

Autism spectrum disorder and beta thalassemia minor: A genetic link?

Hamza AYAYDIN, Hatice TAKATAK